• Analysis of Quantum Computing market Strategies and Forecasts to 2035

    As per Roots Analysis, in order to overcome various challenges related to drug discovery, such as preclinical failure rates, increased time period and heavy capital investments, several pharmaceutical players are currently exploring the potential of quantum computing in drug discovery processes.

    The use of quantum computing in drug discovery is likely to improve the overall R&D productivity by providing better clinical outcomes with accurate predictions of a drug molecule's properties. Overall, this domain is anticipated to gain significant traction, in the foreseen future. Presently, over 45 players around the globe claim to offer quantum computing services across different steps of drug discovery.

    The financial opportunity within the tissue engineering-based regeneration devices has been analyzed across the following segments:

     Drug Discovery Service(s) Offered
     Target Identification / Validation
     Hit Generation / Lead Identification
     Lead Optimization

     Therapeutic Area
     Cardiovascular Disorders
     CNS Disorders
     Dermatological Disorders
     Endocrine Disorders
     Gastrointestinal Disorders
     Immunological Disorders
     Infectious Diseases
     Musculoskeletal Disorders
     Oncological Disorders
     Respiratory Disorders
     Others

     Geographical Regions
     North America
     Europe
     Asia-Pacific
     Latin America
     MENA

    The “Quantum Computing in Drug Discovery Services Market 2023-2035” report features the following companies, which we identified to be key players in this domain:
     Accenture
     Amazon Web Services
     Atos
     Fujitsu
     Huawei
     IBM
     Microsoft
     Xanadu
     XtalPi

    Table of Contents

    1. Preface

    2. Executive Summary

    3. Introduction

    4. Market Landscape: Quantum Computing Software Providers

    5. Company Competitiveness Analysis

    6. Company Profiles: Software Providers

    7. Market Landscape: Hardware Providers

    8. Company Profiles: Hardware Providers

    9. Academic Grants Analysis

    10. Partnerships and Collaborations

    11. Use Case Study

    12. Porter’s Five Forces Analysis

    13. Blue Ocean Strategy

    14. Market Sizing and Opportunity Analysis

    15. Executive Insights

    16. Appendix I- Tabulated Data

    17 Appendix II- List of Companies

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html

    News article
    Global Cell Free Expression Market

    Learn from experts: do you know about these emerging industry trends?
    Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities

    mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Roots Analysis Consulting - the preferred research partner for global firms

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #quantumcomputingcompanies #quantumcomputingreport #quantumcomputingsoftware
    Analysis of Quantum Computing market Strategies and Forecasts to 2035 As per Roots Analysis, in order to overcome various challenges related to drug discovery, such as preclinical failure rates, increased time period and heavy capital investments, several pharmaceutical players are currently exploring the potential of quantum computing in drug discovery processes. The use of quantum computing in drug discovery is likely to improve the overall R&D productivity by providing better clinical outcomes with accurate predictions of a drug molecule's properties. Overall, this domain is anticipated to gain significant traction, in the foreseen future. Presently, over 45 players around the globe claim to offer quantum computing services across different steps of drug discovery. The financial opportunity within the tissue engineering-based regeneration devices has been analyzed across the following segments:  Drug Discovery Service(s) Offered  Target Identification / Validation  Hit Generation / Lead Identification  Lead Optimization  Therapeutic Area  Cardiovascular Disorders  CNS Disorders  Dermatological Disorders  Endocrine Disorders  Gastrointestinal Disorders  Immunological Disorders  Infectious Diseases  Musculoskeletal Disorders  Oncological Disorders  Respiratory Disorders  Others  Geographical Regions  North America  Europe  Asia-Pacific  Latin America  MENA The “Quantum Computing in Drug Discovery Services Market 2023-2035” report features the following companies, which we identified to be key players in this domain:  Accenture  Amazon Web Services  Atos  Fujitsu  Huawei  IBM  Microsoft  Xanadu  XtalPi Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape: Quantum Computing Software Providers 5. Company Competitiveness Analysis 6. Company Profiles: Software Providers 7. Market Landscape: Hardware Providers 8. Company Profiles: Hardware Providers 9. Academic Grants Analysis 10. Partnerships and Collaborations 11. Use Case Study 12. Porter’s Five Forces Analysis 13. Blue Ocean Strategy 14. Market Sizing and Opportunity Analysis 15. Executive Insights 16. Appendix I- Tabulated Data 17 Appendix II- List of Companies To view more details on this report, click on the link https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html News article Global Cell Free Expression Market Learn from experts: do you know about these emerging industry trends? Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #quantumcomputingcompanies #quantumcomputingreport #quantumcomputingsoftware
    WWW.ROOTSANALYSIS.COM
    Quantum Computing Market in Drug Discovery Size, Share, Trends, Growth and Forecasts
    The global quantum computing market in drug discovery is estimated to be USD 411 million in 2022 and is anticipated to grow at a CAGR of 13.6% during the forecast period
    0 Comments 0 Shares